10x Genomics, Inc. , a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific.
10x Genomics stock last closed at $7.68, up 2.26% from the previous day, and has decreased 72.37% in one year. It has underperformed other stocks in the Health Information Services industry by 0.02 percentage points. 10x Genomics stock is currently +13.27% from its 52-week low of $6.78, and -73.85% from its 52-week high of $29.37.
At the moment, there are 122.3M shares of TXG outstanding. The market cap of TXG is $939.28M. In the last 24 hours, 6.99M TXG shares were traded.
How to Buy 10x Genomics Stock
Wondering how to invest in 10x Genomics stock? Here's how.
Decide where to buy 10x Genomics stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy 10x Genomics stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Select your method of payment and add your info.
Research 10x Genomics stock: The 10x Genomics ticker symbol is TXG. Is 10x Genomics stock a good investment? Should you buy shares of TXG? How do TXG's underlying business fundamentals look? Do top analysts think 10x Genomics is a good buy? Why has TXG's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if TXG is a good stock to buy).
Make your TXG purchase: Decide if you will purchase TXG shares at the current market price or use a limit order to buy TXG stock at a given price.
Track your TXG position: Create a watchlist to monitor your new investment in 10x Genomics stock.
Step 1: Decide where to buy 10x Genomics stock
You will need an online brokerage account to access the NASDAQ market and buy TXG shares.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global markets: From Tech to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've selected the right brokerage, you need to fill out some personal info so you can buy TXG stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research 10x Genomics stock
Once you have selected the best place to buy 10x Genomics stock, it's important to research their stock prior to investing, so you can understand the risk as well as the upside.
10x Genomics shares quick numbers
TXG Price
$7.68
1w %
-7.19%
1y %
-72.37%
5y %
-89.7%
P/E
-5.05x
P/B
1.32x
P/S
1.51x
PEG
N/A
Revenue
$610.79M
Earnings
-$182.63M
Fore. Rev. Growth
5%
Fore. Earn. Growth
N/A
Market Cap
$939.28M
Next Earnings
Apr 28, 2025
Next Dividend
N/A
10x Genomics Overview
WallStreetZen was built to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on TXG's stock page.
Is TXG stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge TXG's intrinsic value.
Using relative valuations metrics:
TXG may be undervalued based on its P/B ratio of 1.32x, relative to Health Information Services industry P/B ratio of 3.29x
Total TXG debt is lower than 5 years ago, relative to shareholder equity.
TXG has $393.40M in cash and short term investments. This is enough to cover its annual cash burn of $5.73M.
TXG has a low debt to equity ratio of 0.29.
There are more short-term assets than short-term liabilities on the TXG balance sheet.
TXG has cash burn of 5729000. It has sufficient cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the TXG balance sheet.
Signs that TXG is not financially healthy:
TXG profit margin has gone up by 0.11 percentage points in the past year, but the company is still unprofitable.
Do analysts think it's a good time to buy 10x Genomics stock
Out of 9 sell side analysts who track TXG, the consensus analyst rating on TXG is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest TXG Analyst Forecasts
Dan Leonard, a top 9% analyst from UBS maintains TXG with a hold rating and lowers their TXG price target from $20.00 to $14.00, on Feb 13, 2025.
Daniel Arias, a top 25% analyst from Stifel Nicolaus maintains TXG with a strong buy rating and lowers their TXG price target from $21.00 to $18.00, on Feb 13, 2025.
Mike Kratky, a top 10% analyst from Leerink Partners downgrades TXG to a hold rating and lowers their TXG price target from $25.00 to $12.00, on Feb 13, 2025.
Matthew Sykes, a top 7% analyst from Goldman Sachs maintains TXG with a strong sell rating and lowers their TXG price target from $16.00 to $14.00, on Oct 30, 2024.
Last year, TXG revenue was $610.79M. Over the past 5 year, TXG's revenue has increased by 19.96% per year. This was slower than the Health Information Services industry average of 22.41%.
No, 10x Genomics doesn't provide an income stream by paying out dividends.
What others are saying about TXG
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your TXG purchase
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are generally the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at an exact dollar amount, use a limit order.
Hit the Open button and your broker will place the order.
If you require more assistance buying stocks on eToro, click the how to video below:
How much does it cost to buy one 10x Genomics share?
As of Apr 21, 2025, it costs $7.68 to buy one share of 10x Genomics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.391 shares of TXG.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.